Xeris Biopharma Holdings
XERS
XERS
162 hedge funds and large institutions have $223M invested in Xeris Biopharma Holdings in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 60 increasing their positions, 33 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 143 → 162 (+19)
1.18% more ownership
Funds ownership: 42.9% → 44.08% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
162
Holding in Top 10
2
Calls
$857K
Puts
$236K
Top Buyers
| 1 | +$4.92M | |
| 2 | +$2.82M | |
| 3 | +$2.56M | |
| 4 |
JP Morgan Chase
New York
|
+$2.21M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.01M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$9.46M | |
| 3 | -$3.2M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$2.02M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$790K |